Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure.
Science
; 377(6613): 1399-1406, 2022 09 23.
Article
em En
| MEDLINE
| ID: mdl-36137043
ABSTRACT
Tissue-tissue communication by endocrine factors is a vital mechanism for physiologic homeostasis. A systems genetics analysis of transcriptomic and functional data from a cohort of diverse, inbred strains of mice predicted that coagulation factor XI (FXI), a liver-derived protein, protects against diastolic dysfunction, a key trait of heart failure with preserved ejection fraction. This was confirmed using gain- and loss-of-function studies, and FXI was found to activate the bone morphogenetic protein (BMP)-SMAD1/5 pathway in the heart. The proteolytic activity of FXI is required for the cleavage and activation of extracellular matrix-associated BMP7 in the heart, thus inhibiting genes involved in inflammation and fibrosis. Our results reveal a protective role of FXI in heart injury that is distinct from its role in coagulation.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fator XI
/
Proteína Morfogenética Óssea 7
/
Insuficiência Cardíaca
/
Fígado
/
Miocárdio
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article